BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 29461039)

  • 1. Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).
    Nichols DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2331-2343. PubMed ID: 29461039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration.
    Oram M
    Hist Psychiatry; 2016 Sep; 27(3):290-306. PubMed ID: 27194113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide.
    Smith DE; Raswyck GE; Davidson LD
    J Psychoactive Drugs; 2014; 46(1):3-10. PubMed ID: 24830180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albert Hofmann, the father of LSD (1906-2008).
    Fusar-Poli P; Borgwardt S
    Neuropsychobiology; 2008; 58(1):53-4. PubMed ID: 18799895
    [No Abstract]   [Full Text] [Related]  

  • 5. Modern Clinical Research on LSD.
    Liechti ME
    Neuropsychopharmacology; 2017 Oct; 42(11):2114-2127. PubMed ID: 28447622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20
    Aday JS; Bloesch EK; Davoli CC
    J Psychoactive Drugs; 2019; 51(3):210-217. PubMed ID: 30836890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DARK Classics in Chemical Neuroscience: Psilocybin.
    Geiger HA; Wurst MG; Daniels RN
    ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Past and Future of Psychedelic Science: An Introduction to This Issue.
    Doblin RE; Christiansen M; Jerome L; Burge B
    J Psychoactive Drugs; 2019; 51(2):93-97. PubMed ID: 31132970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LSD before Leary. Sidney Cohen's critique of 1950s psychedelic drug research.
    Novak SJ
    Isis; 1997 Mar; 88(1):87-110. PubMed ID: 9154737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of alcoholism using psychedelic drugs: a review of the program of research.
    Mangini M
    J Psychoactive Drugs; 1998; 30(4):381-418. PubMed ID: 9924844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of lysergic acid diethylamide (LSD) in the treatment of addictions: historical perspectives and future prospects.
    Liester MB
    Curr Drug Abuse Rev; 2014; 7(3):146-56. PubMed ID: 25563445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychedelics and Psychedelic-Assisted Psychotherapy.
    Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
    Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychedelics: Where we are now, why we got here, what we must do.
    Belouin SJ; Henningfield JE
    Neuropharmacology; 2018 Nov; 142():7-19. PubMed ID: 29476779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelic drugs: the ups and downs of ecstasy.
    Check E
    Nature; 2004 May; 429(6988):126-8. PubMed ID: 15141183
    [No Abstract]   [Full Text] [Related]  

  • 15. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.
    Dunlap LE; Andrews AM; Olson DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2408-2427. PubMed ID: 30001118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelic Therapy: A Primer for Primary Care Clinicians-Lysergic Acid Diethylamide (LSD).
    Beutler BD; Shinozuka K; Tabaac BJ; Arenas A; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e104-e111. PubMed ID: 38518267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of consciousness and mystical-type experiences after acute LSD in humans.
    Liechti ME; Dolder PC; Schmid Y
    Psychopharmacology (Berl); 2017 May; 234(9-10):1499-1510. PubMed ID: 27714429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].
    Majić T; Jungaberle H; Schmidt TT; Zeuch A; Hermle L; Gallinat J
    Fortschr Neurol Psychiatr; 2017 Jul; 85(7):383-392. PubMed ID: 28768346
    [No Abstract]   [Full Text] [Related]  

  • 19. Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Dowling G; Wallach J; Halberstadt AL
    Drug Test Anal; 2019 Aug; 11(8):1122-1133. PubMed ID: 31083768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.
    Ezeaka UC; Kim HJJ; Laprairie RB
    Curr Top Med Chem; 2023; 23(23):2232-2241. PubMed ID: 37409550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.